Home Body size measurements, digit ratio (2D:4D) and oestrogen and progesterone receptors’ expressions in juvenile gigantomastia
Article
Licensed
Unlicensed Requires Authentication

Body size measurements, digit ratio (2D:4D) and oestrogen and progesterone receptors’ expressions in juvenile gigantomastia

  • Anna Kasielska-Trojan ORCID logo EMAIL logo , Marian Danilewicz , Aneta Sitek and Boguslaw Antoszewski
Published/Copyright: February 21, 2020

Abstract

Background

Juvenile breast hypertrophy is characterised by massive enlargement of the breast in the peri-pubertal period. We aimed to analyse body size measurements (body mass index [BMI], waist-to-hip circumference ratio [WHR]), digit ratio (ratio of II and IV digits’ length [2D:4D]) and oestrogen receptor (ER) alpha (ERα) and progesterone receptors (PRs) in the breast gland in women with juvenile gigantomastia.

Methods

The study involved 30 women (mean age 25.7 years) (mean age of onset – 14.8 years). ERα and PR expressions were detected immunohistochemically in breast gland samples. For comparison, 100 controls (50 women and 50 men) were included.

Results

BMI and WHR in women with gigantomastia were higher than in control women and the former had a higher WHR than expected for their BMI. 2D:4D in the examined women did not differ from that in control women. However, left 2D:4D was negatively related to the age of gigantomastia onset. There were no correlations between ER and PR expressions and the analysed body and digit ratios.

Conclusions

The lack of a relationship between 2D:4D and juvenile breast hypertrophy may suggest that foetal exposure to sex hormones may not be crucial in its aetiology. However, the link between high left 2D:4D and early development of gigantomastia suggests that prenatal sex hormones have a role in its development timing. High WHR, and particularly high WHR relative to BMI, may indicate that these women had at some stage of development higher circulating androgens, which may have been converted to oestrogens in breasts due to local aromatase activity. Verification of this hypothesis could allow consideration of the role of aromatase inhibitors in juvenile breast hypertrophy.


Corresponding author: Anna Kasielska-Trojan, MD, PhD, Plastic, Reconstructive and Aesthetic Surgery Clinic, Institute of Surgery, Medical University of Lodz, Kopcinskiego 22, Lodz 90-153, Poland, Phone: (004842) 6776742, Fax: (004842) 6776749

  1. Disclosure

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Research funding: None.

  4. Employment/leadership: None.

  5. Honorarium: None.

  6. Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  7. Conflict of interest: The authors declare that they have no conflict of interest.

References

1. Dancey A, Khan M, Dawson J, Peart F. Gigantomastia – a classification and review of the literature. J Plast Reconstr Aesthet Surg 2008;61:493–502.10.1016/j.bjps.2007.10.041Search in Google Scholar PubMed

2. Taylor CJ, Chester DL. Bilateral breast reduction surgery in elderly women: a retrospective review of outcomes. J Plast Reconstr Aesthet Surg 2012;65:304–11.10.1016/j.bjps.2011.09.032Search in Google Scholar PubMed

3. Netscher DT, Meade RA, Goodman CM, Brehm BJ, Friedman JD, et al. Physical and psychosocial symptoms among 88 volunteer subjects compared to patients seeking plastic surgery procedures to the breast. Plast Reconstr Surg 2000;105:2366–73.10.1097/00006534-200006000-00009Search in Google Scholar PubMed

4. Govrin-Yehudain J, Kogan L, Cohen HI, Falik-Zaccai TC. Familial juvenile hypertrophy of the breast. J Adolesc Health 2004;35:151–5.10.1016/j.jadohealth.2003.09.017Search in Google Scholar PubMed

5. Latham K, Fernandez S, Iteld L, Panthaki Z, Armstrong MB, et al. Pediatric breast deformity. J Craniofac Surg 2006;17:454–67.10.1097/00001665-200605000-00012Search in Google Scholar PubMed

6. Morimoto T, Komaki K, Mori T, Sasa M, Miki H, et al. Juvenile gigantomastia: report of a case. Surg Today 1993;23:260–4.10.1007/BF00309238Search in Google Scholar PubMed

7. O’Hare PM, Frieden IJ. Virginal breast hypertrophy. Pediatr Dermatol 2000;17:277–81.10.1046/j.1525-1470.2000.01774.xSearch in Google Scholar PubMed

8. Jabs AD, Frantz AG, Smith-Vaniz A, Hugo NE. Mammary hypertrophy is not associated with increased estrogen receptors. Plast Reconstr Surg 1990;86:64–6.10.1097/00006534-199007000-00010Search in Google Scholar PubMed

9. Gliosci A, Presutti F. Virginal gigantomastia: validity of combined surgical and hormonal treatments. Aesthetic Plast Surg 1993;17:61–5.10.1007/BF00455051Search in Google Scholar PubMed

10. Sperling RL, Gold JJ. Use of an anti-estrogen after a reduction mammaplasty to prevent recurrence of virginal hypertrophy of breasts. Case report. Plast Reconstr Surg 1973;52:439–42.10.1097/00006534-197352040-00030Search in Google Scholar

11. Arscott GD, Craig HR, Gabay L. Failure of bromocriptine therapy to control juvenile mammary hypertrophy. Br J Plast Surg 2001;54:720–3.10.1054/bjps.2001.3691Search in Google Scholar PubMed

12. Demir K, Unuvar T, Eren S, Abaci A, Bober E. Tamoxifen as first-line treatment in a premenarchal girl with juvenile breast hypertrophy. J Pediatr Adolesc Gynecol 2010;23:e133–6.10.1016/j.jpag.2009.11.003Search in Google Scholar PubMed

13. Karagüzel G, Bilen S, Karaçal N, Yıldız K, Livaoğlu M. Virginal breast hypertrophy: different presentations of 2 cases and the role of tamoxifen as an adjuvant therapy. J Pediatr Adolesc Gynecol 2016;29:e71–4.10.1016/j.jpag.2016.03.008Search in Google Scholar PubMed

14. Pruthi S, Jones KN. Nonsurgical management of fibroadenoma and virginal breast hypertrophy. Semin Plast Surg 2013;27:62–6.10.1055/s-0033-1343997Search in Google Scholar PubMed PubMed Central

15. Manning JT. Digit Ratio: a pointer to fertility, behavior, and health. New Brunswick: Rutgers University Press, 2002.Search in Google Scholar

16. Manning JT. Resolving the role of prenatal sex steroids in the development of digit ratio. Proc Natl Acad Sci USA 2011;108:16143–4.10.1073/pnas.1113312108Search in Google Scholar PubMed PubMed Central

17. Zheng Z, Cohn MJ. Developmental basis of the sexually dimorphic digit ratio. Proc Natl Acad Sci USA 2011;108:16289–94.10.1073/pnas.1108312108Search in Google Scholar PubMed PubMed Central

18. Ertuğrul B, Barış Özener B, Pawłowski B. Prenatal exposure to oestrogens estimated by digit ratio (2d/4d) and breast size in young nulliparous women. Ann Hum Biol 2019:1–4. doi: 10.1080/03014460.2019.1699955 [Epub ahead of print].10.1080/03014460.2019.1699955Search in Google Scholar PubMed

19. Kasielska-Trojan A, Antoszewski B. Can digit ratio (2D:4D) studies be helpful in explaining the aetiology of idiopathic gynecomastia? Early Hum Dev 2015;91:57–61.10.1016/j.earlhumdev.2014.12.001Search in Google Scholar PubMed

20. Muller DC, Baglietto L, Manning JT, McLean C, Hopper JL, et al. Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study. Br J Cancer 2012;107:1631–6.10.1038/bjc.2012.418Search in Google Scholar PubMed PubMed Central

21. Crewther B, Cook C, Kilduff L, Manning J. Digit ratio (2D:4D) and salivary testosterone, oestradiol and cortisol levels under challenge: evidence for prenatal effects on adult endocrine responses. Early Hum Dev 2015;91:451–6.10.1016/j.earlhumdev.2015.04.011Search in Google Scholar PubMed

22. Klimek M, Galbarczyk A, Colleran H, Thune I, Ellison PT, et al. Digit ratio (2D:4D) does not correlate with daily 17β-estradiol and progesterone concentrations in healthy women of reproductive age. Am J Hum Biol 2015;27:667–73.10.1002/ajhb.22717Search in Google Scholar PubMed

23. Richards G, Klimek M, Jasienska G, Marcinkowska UM. Digit ratio (2D:4D) and circulating testosterone, oestradiol, and progesterone levels across the menstrual cycle. Early Hum Dev 2018;117:68–73.10.1016/j.earlhumdev.2017.12.006Search in Google Scholar PubMed

24. Kasielska-Trojan A, Danilewicz M, Strużyna J, Bugaj M, Antoszewski B. The role of oestrogen and progesterone receptors in gigantomastia. Arch Med Sci DOI: https://doi.org/10.5114/aoms.2019.88280 [Epub ahead of print].10.5114/aoms.2019.88280Search in Google Scholar

25. Mondragón-Ceballos R, García Granados MD, Cerda-Molina AL, Chavira-Ramírez R, Hernández-López LE. Waist-to-hip ratio, but not body mass index, is associated with testosterone and estradiol concentrations in young women. Int J Endocrinol 2015;2015:654046.10.1155/2015/654046Search in Google Scholar PubMed PubMed Central

26. Manning JT, Leinster SJ. The ratio of 2nd to 4th digit length and age at presentation of breast cancer: a link with prenatal oestrogen? Breast 2001;10:355–7.10.1054/brst.2001.0284Search in Google Scholar

27. Manning JT, Fink B. Is low digit ratio linked with late menarche? Evidence from the BBC internet study. Am J Hum Biol 2011;23:527–33.10.1002/ajhb.21186Search in Google Scholar PubMed

28. Gooding DC, Chambers BH. Age of pubertal onset and 2nd to 4th digit ratios: preliminary findings. Early Hum Dev 2018;116:28–32.10.1016/j.earlhumdev.2017.10.007Search in Google Scholar PubMed

29. Li T, Meng Y, Yao R, Han H, Wu L, et al. The associations between left-hand digit ratio (2D:4D) and puberty characteristics among Chinese girls. Early Hum Dev 2019;130:22–6.10.1016/j.earlhumdev.2019.01.007Search in Google Scholar PubMed

30. Leslie M. The mismeasure of hands? Science 2019;364: 923–5.10.1126/science.364.6444.923Search in Google Scholar PubMed

31. Honekopp J, Watson S. Meta-analysis of digit ratio 2D:4D shows greater sex difference in the right hand. Am J Hum Biol 2010;22:619–30.10.1002/ajhb.21054Search in Google Scholar PubMed

32. Hönekopp J, Schuster M. A meta-analysis on 2D:4D and athletic prowess: substantial relationships but neither hand out-predicts the other. Pers Individ Dif 2010;48:4–10.10.1016/j.paid.2009.08.009Search in Google Scholar

33. Honekopp J. Digit ratio 2D:4D in relation to autism spectrum disorders, empathizing, and systemizing: a quantitative review. Autism Res 2012;5:221–30.10.1002/aur.1230Search in Google Scholar PubMed

34. Siegmann EM, Bouna-Pyrrou P, Lenz B, Kornhuber J. Digit ratio (2D:4D) in relation to substance and computer use: a meta-analysis. J Neural Transm (Vienna) 2019;126:623–36.10.1007/s00702-019-02002-2Search in Google Scholar PubMed PubMed Central

35. Grimbos T, Dawood K, Burriss RP, Zucker KJ, Puts DA. Sexual orientation and the second to fourth finger length ratio: a meta-analysis in men and women. Behav Neurosci 2010;124:278–87.10.1037/a0018764Search in Google Scholar PubMed

36. Kasielska-Trojan A, Danilewicz M, Antoszewski B. Is there a rationale behind pharmacotherapy in idiopathic gynecomastia? Horm Res Paediatr 2018;89:408–12.10.1159/000487753Search in Google Scholar PubMed

37. Akgül S, Kanbur N, Güçer S, Safak T, Derman O. The histopathological effects of tamoxifen in the treatment of pubertal gynecomastia. J Pediatr Endocrinol Metab 2012;25:753–5.10.1515/jpem-2012-0105Search in Google Scholar PubMed

38. Das L, Rai A, Vaiphei K, Garg A, Mohsina S, et al. Idiopathic gigantomastia: newer mechanistic insights implicating the paracrine milieu. Endocrine 2019;66:166–77.10.1007/s12020-019-02065-xSearch in Google Scholar PubMed

Received: 2019-11-14
Accepted: 2020-01-16
Published Online: 2020-02-21
Published in Print: 2020-03-26

©2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Vitamin D status in Israeli pediatric type 1 diabetes patients: the AWeSoMe Study Group experience and literature review
  4. Metabolic features and changes in glucose-induced serum glucagon-like peptide-1 levels in children with hypothalamic obesity
  5. Assessment of intima-media thickness of the carotid artery and intraluminal diameter of the brachial artery as cardiovascular risk markers in Brazilian adolescents with overweight or obesity
  6. The role of LCPUFA-ω3 on the obesity-associated hyperandrogenemia of pubertal girls: secondary analysis of a randomized clinical trial
  7. Genetic variants of the phenylalanine hydroxylase gene in patients with phenylketonuria in the northeast of Iran
  8. Oral health status of children with phenylketonuria
  9. Birth weight related blood concentrations of the neurotransmission amino acids glutamine plus glutamate, phenylalanine and tyrosine in full-term breastfed infants perinatally
  10. Hyperthyrotropinemia is common in preterm infants who are born small for gestational age
  11. Radioactive iodine therapy for pediatric Graves’ disease: a single-center experience over a 10-year period
  12. The decision-making levels of urine tetrasaccharide for the diagnosis of Pompe disease in the Turkish population
  13. A questionnaire study on sleep disturbances associated with Prader-Willi syndrome
  14. Body size measurements, digit ratio (2D:4D) and oestrogen and progesterone receptors’ expressions in juvenile gigantomastia
  15. The effect of celiac disease and gluten-free diet on pubertal development: a two-center study
  16. Observational study of disorders of sex development in Yaounde, Cameroon
  17. Letter to the Editor
  18. Reforming the male Tanner genital scale
  19. Short Communication
  20. The association between vitamin D levels and precocious puberty: a meta-analysis
  21. Case Reports
  22. Partial trisomy 9p and 14q microduplication in a patient with growth retardation: a case report and review of the literature
  23. Two different missense mutations of PEX genes in two similar patients with severe Zellweger syndrome: an argument on the genotype-phenotype correlation
  24. Patient report
  25. Marked phenotypic variable expression among brothers with duplication of Xq27.1 involving the SOX3 gene
  26. Case Report
  27. Does the risk of arterial hypertension increase in the course of triptorelin treatment?
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0534/html
Scroll to top button